newsfilter
← Latest News
GlobeNewswire·

Neoleukin Therapeutics Announces Third Quarter 2020 Financial Results and Corporate Update

-NL-201 IND submission anticipated by year end 2020- -Clinical Trial Notification application submitted in Australia- -Ended 3rd quarter with $201.2 million in cash and cash equivalents- ...